01 43GLAXO GRP LTD
02 35GLAXOSMITHKLINE
01 147439393
02 37488827
03 37498440
04 48183257
05 38309572
06 78511304
07 58534281
08 58746242
09 39750726
10 211090294
11 611116721
12 311116721*PED
13 67439393*PED
14 48511304*PED
15 58534281*PED
16 58746242*PED
01 20Y
02 58Blank
01 46Y
02 32Blank
01 62025-04-27
02 142025-05-21
03 42025-07-27
04 62025-11-21
05 72027-06-14
06 42027-12-14
07 32027-12-18
08 62029-02-26
09 32029-08-26
10 52030-03-08
11 52030-09-08
12 52030-10-11
13 52030-11-29
14 52031-04-11
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2099
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1424
Delist Requested :
Patent Use Description : LONG-TERM, ONCE DAILY ...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-04-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-07-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1401
Delist Requested :
Patent Use Description : INDICATED FOR LONG-TER...
Patent Expiration Date : 2029-02-26
